Back to News
Market Impact: 0.55

ASML Quantitative Stock Analysis

ASMLNDAQ
Company FundamentalsAnalyst InsightsTechnology & Innovation
ASML Quantitative Stock Analysis

Validea's guru fundamental report indicates that ASML Holding NV (ADR) (ASML) receives a 100% rating based on their Patient Investor model, which is based on the published strategy of Warren Buffett. The strategy identifies firms with predictable profitability, low debt, and reasonable valuations, all of which ASML currently exhibits, according to the report. The report suggests strong interest in the stock based on the firm’s underlying fundamentals and valuation.

Analysis

ASML Holding NV (ASML), a large-cap growth stock within the Semiconductors industry, has achieved a perfect 100% rating according to Validea's 'Patient Investor' model, which emulates Warren Buffett's investment principles. This score indicates strong interest, as the strategy prioritizes companies demonstrating long-term, predictable profitability, low leverage, and reasonable valuations. The report confirms ASML meets all nine fundamental criteria evaluated by this model: Earnings Predictability, Debt Service, Return on Equity, Return on Total Capital, Free Cash Flow, Use of Retained Earnings, Share Repurchase, Initial Rate of Return, and Expected Return. This comprehensive positive assessment underscores ASML's robust underlying fundamentals and its current stock valuation, aligning with the strongly positive sentiment (0.85 overall, 0.9 for ASML specifically) associated with this evaluation.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.85

Ticker Sentiment

ASML0.90
NDAQ0.00

Key Decisions for Investors

  • Given ASML's exceptional 100% rating on Validea's Buffett-aligned 'Patient Investor' model, investors should evaluate the stock for its demonstrated long-term predictable profitability, low debt profile, and reasonable valuation.
  • The company's successful adherence to all nine key fundamental metrics, including strong earnings predictability and high returns on capital, suggests that ASML's current financial health and valuation may present a compelling case for long-term investment.
  • Investors should continue to monitor ASML's performance against these fundamental criteria, as sustained strength in areas like free cash flow generation and efficient use of retained earnings would further validate the positive outlook highlighted by the Validea report.